series-b
Stage
2014
Founded
1
Investors
About
Eligo Bioscience develops programmable biotherapeutic nanobots that target specific bacteria in the human microbiome to treat diseases such as inflammatory bowel disease, colorectal cancer, and acne.
Explore Eligo Bioscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.